Atlas Trials

A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

Clinical trial NCT05548556 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05548556
Sponsor
Hoffmann-La Roche
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Facioscapulohumeral Muscular Dystrophy (FSHD)
Start date
2023-02-07
Primary completion
2025-05-02
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.